Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Engler

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
QJM : Monthly Journal of the Association of Physicians|October 23, 2002
Conflicts of interestR L Engler
The Western Journal of Medicine|June 1, 1977
Historical and physical findings in patients with aortic valve diseaseR L Engler
The New England Journal of Medicine|December 29, 1998
Diabetes and coronary heart diseaseR L Engler
The American Journal of Cardiology|March 7, 1989
Free radical and granulocyte-mediated injury during myocardial ischemia and reperfusionR L Engler
Journal of Cardiac Surgery|May 1, 1994
Harnessing nature's own cardiac defense mechanism with acadesine, an adenosine regulating agent: importance of the endotheliumR L Engler
Journal of the American College of Cardiology|June 17, 1998
Do sulfonylurea drugs limit coronary vasodilator reserve?R L Engler
Circulation|August 1, 1991
Adenosine. The signal of life?R L Engler
The New England Journal of Medicine|October 3, 1991
Lidoflazine in the treatment of comatose survivors of cardiac arrestR L Engler
The New England Journal of Medicine|September 28, 1989
The arrhythmia consultation programR L Engler
Circulation|April 1, 1980
Comparison of i.v. quinidine and disopyramideR L Engler
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
QJM : Monthly Journal of the Association of Physicians|October 23, 2002
Conflicts of interestR L Engler
The Western Journal of Medicine|June 1, 1977
Historical and physical findings in patients with aortic valve diseaseR L Engler
The New England Journal of Medicine|December 29, 1998
Diabetes and coronary heart diseaseR L Engler
The American Journal of Cardiology|March 7, 1989
Free radical and granulocyte-mediated injury during myocardial ischemia and reperfusionR L Engler
Journal of Cardiac Surgery|May 1, 1994
Harnessing nature's own cardiac defense mechanism with acadesine, an adenosine regulating agent: importance of the endotheliumR L Engler
Journal of the American College of Cardiology|June 17, 1998
Do sulfonylurea drugs limit coronary vasodilator reserve?R L Engler
Circulation|August 1, 1991
Adenosine. The signal of life?R L Engler
The New England Journal of Medicine|October 3, 1991
Lidoflazine in the treatment of comatose survivors of cardiac arrestR L Engler
The New England Journal of Medicine|September 28, 1989
The arrhythmia consultation programR L Engler
Circulation|April 1, 1980
Comparison of i.v. quinidine and disopyramideR L Engler
Pageof 7